company background image
LUMITO logo

Lumito NGM:LUMITO Stock Report

Last Price

kr1.41

Market Cap

kr303.5m

7D

0.4%

1Y

-29.0%

Updated

27 Mar, 2024

Data

Company Financials

LUMITO Stock Overview

Lumito AB (publ) engages in the research and development of imaging technology in Sweden.

LUMITO fundamental analysis
Snowflake Score
Valuation1/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Lumito AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Lumito
Historical stock prices
Current Share Pricekr1.41
52 Week Highkr0
52 Week Lowkr0
Beta0.93
1 Month Change0.86%
3 Month Change-10.31%
1 Year Change-29.00%
3 Year Change-60.67%
5 Year Change-33.49%
Change since IPO-30.88%

Recent News & Updates

Will Lumito (NGM:LUMITO) Spend Its Cash Wisely?

Jan 02
Will Lumito (NGM:LUMITO) Spend Its Cash Wisely?

We're Keeping An Eye On Lumito's (NGM:LUMITO) Cash Burn Rate

Sep 19
We're Keeping An Eye On Lumito's (NGM:LUMITO) Cash Burn Rate

Shareholder Returns

LUMITOSE Medical EquipmentSE Market
7D0.4%4.3%1.9%
1Y-29.0%-3.4%17.1%

Return vs Industry: LUMITO underperformed the Swedish Medical Equipment industry which returned -3.9% over the past year.

Return vs Market: LUMITO underperformed the Swedish Market which returned 19% over the past year.

Price Volatility

Is LUMITO's price volatile compared to industry and market?
LUMITO volatility
LUMITO Average Weekly Movement11.2%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.9%
10% least volatile stocks in SE Market3.4%

Stable Share Price: LUMITO's share price has been volatile over the past 3 months.

Volatility Over Time: LUMITO's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
201015Mattias Lundinhttps://lumito.se

Lumito AB (publ) engages in the research and development of imaging technology in Sweden. It offers tissue diagnostics products, including instruments that are used to provide pathologists and biomedical analysts with visual representations of tissue samples as a basis for diagnosis; and reagents, a staining fluids used to stain tissue samples so that a higher contrast can be achieved in imaging. The company was incorporated in 2010 and is headquartered in Lund, Sweden.

Lumito AB (publ) Fundamentals Summary

How do Lumito's earnings and revenue compare to its market cap?
LUMITO fundamental statistics
Market capkr303.46m
Earnings (TTM)-kr25.80m
Revenue (TTM)n/a

0.0x

P/S Ratio

-11.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
LUMITO income statement (TTM)
Revenuekr0
Cost of Revenue-kr13.93m
Gross Profitkr13.93m
Other Expenseskr39.74m
Earnings-kr25.80m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.12
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio9.7%

How did LUMITO perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.